We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$15B
AUM Growth
+$614M
Cap. Flow
-$689M
Cap. Flow %
-4.6%
Top 10 Hldgs %
9.86%
Holding
499
New
33
Increased
63
Reduced
287
Closed
34

Top Sells

Rank Stock Value
1
PODD icon
Insulet
PODD
+$86.4M
2
SAGE
Sage Therapeutics
SAGE
+$56.2M
3
WEC icon
WEC Energy
WEC
+$49.5M
4
AOS icon
A.O. Smith
AOS
+$48.9M
5
CHRW icon
C.H. Robinson
CHRW
+$41.8M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 17.37%
3 Industrials 15.16%
4 Consumer Discretionary 13.51%
5 Financials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLB icon
376
Protolabs
PRLB
$1.79B
$5.99M 0.04%
58,934
-2,000
-3% -$198K
UAL icon
377
United Airlines
UAL
$39.4B
$5.98M 0.04%
67,900
-4,600
-6% -$413K
DAR icon
378
Darling Ingredients
DAR
$9.64B
$5.9M 0.04%
+210,100
New +$4.68M
GRMN
379
Garmin
GRMN
$56.7B
$5.88M 0.04%
+60,250
New +$5.62M
ICUI icon
380
ICU Medical
ICUI
$4.21B
$5.87M 0.04%
31,385
-900
-3% -$155K
ENV
381
DELISTED
ENVESTNET, INC.
ENV
$5.75M 0.04%
82,603
-2,700
-3% -$176K
FN icon
382
Fabrinet
FN
$15.6B
$5.65M 0.04%
87,073
-2,900
-3% -$168K
TER icon
383
Teradyne
TER
$57.6B
$5.63M 0.04%
82,500
-5,700
-6% -$362K
BCPC
384
Balchem Corp
BCPC
$5.38B
$5.51M 0.04%
54,258
-1,900
-3% -$192K
POWI icon
385
Power Integrations
POWI
$3.38B
$5.4M 0.04%
109,166
-3,800
-3% -$175K
ADC icon
386
Agree Realty
ADC
$9.34B
$5.19M 0.03%
+73,925
New +$5.45M
MEDP icon
387
Medpace
MEDP
$16.1B
$5.13M 0.03%
61,025
-2,000
-3% -$155K
AIN icon
388
Albany International
AIN
$2.11B
$5.09M 0.03%
67,055
-2,200
-3% -$183K
TT icon
389
Trane Technologies
TT
$101B
$4.97M 0.03%
37,400
-2,500
-6% -$317K
DSGX icon
390
Descartes Systems
DSGX
$6.44B
$4.93M 0.03%
115,516
-4,100
-3% -$167K
AVGO icon
391
Broadcom
AVGO
$1.85T
$4.84M 0.03%
153,000
-11,000
-7% -$334K
BMY icon
392
Bristol-Myers Squibb
BMY
$133B
$4.81M 0.03%
+75,000
New +$4.3M
PLXS icon
393
Plexus
PLXS
$6.72B
$4.66M 0.03%
60,504
-2,000
-3% -$145K
ROST icon
394
Ross Stores
ROST
$80.5B
$4.26M 0.03%
36,600
-220,500
-86% -$24.8M
COF icon
395
Capital One
COF
$128B
$4.2M 0.03%
40,800
-2,800
-6% -$270K
PLUS icon
396
ePlus
PLUS
$2.42B
$4.18M 0.03%
99,124
-3,200
-3% -$130K
ITGR icon
397
Integer Holdings
ITGR
$4.12B
$4.16M 0.03%
51,700
-800
-2% -$61.1K
FWRD icon
398
Forward Air
FWRD
$444M
$4.15M 0.03%
59,300
-900
-1% -$61K
AMBA icon
399
Ambarella
AMBA
$3.77B
$4.14M 0.03%
68,370
-2,300
-3% -$127K
VRTU
400
DELISTED
Virtusa Corporation
VRTU
$4.09M 0.03%
90,263
-2,900
-3% -$118K

Similar funds

Carillon Tower Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, Carillon Tower Advisers held 499 positions worth $15B, up 4.3% from $14.4B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Carillon Tower Advisers withdrew a net $689M in Q4 2019, closing 34 positions and reducing 287 holdings. Its most notable exit was Insulet, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in Seagen Inc. Common Stock worth $48.8M.

  • Carillon Tower Advisers's largest Q4 2019 buy was Seagen Inc. Common Stock: 426,867 shares worth $48.8M.
  • Carillon Tower Advisers added most to Corpay in Q4 2019, an estimated $58.8M increase.
  • Carillon Tower Advisers's biggest Q4 2019 reduction was WEC Energy, cutting an estimated $49.5M.
  • Carillon Tower Advisers fully exited Insulet in Q4 2019, selling an estimated $86.4M.
  • Carillon Tower Advisers's ten largest holdings make up 9.9% of its $15B portfolio in Q4 2019.
  • Carillon Tower Advisers opened 33 new positions and closed 34 in Q4 2019.
  • Carillon Tower Advisers's portfolio value rose 4.3% quarter-over-quarter to $15B.

Based on Carillon Tower Advisers's 13F filing for Q4 2019, filed 11 Feb 2020.